REG - Clontarf Energy PLC - Preliminary Results
06/06/2025 07:00
For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250606:nRSF7079La&default-theme=true
RNS Number : 7079L Clontarf Energy PLC 06 June 2025
6 June 2025
Clontarf Energy plc
("Clontarf" or "the Company")
Preliminary Results for the Year Ended 31 December 2024
Clontarf Energy, the oil and gas exploration company focused on Bolivia and
Ghana today announces its preliminary results for the year ending 31 December
2024.
The Company expects to shortly publish its 2024 Annual Report & Accounts
and a further update will be made in this regard as and when appropriate.
This announcement contains inside information for the purposes of Article 7 of
Regulation 596/2014.
For further information please visit http://clontarfenergy.com
(http://clontarfenergy.com) or contact:
Clontarf Energy +353 (0) 1 833 2833
David Horgan, Chairman
Jim Finn, Director
Nominated & Financial Adviser +44 (0) 20 7409 3494
Strand Hanson Limited
Rory Murphy
Ritchie Balmer
Broker +44 (0) 207 399 9400
Novum Securities Limited
Colin Rowbury
Public Relations +44 (0) 207 138 3206
BlytheRay
Megan Ray
Teneo +353 (0) 1 661 4055
Luke Hogg
Alan Tyrrell
Mollie McLernon
Molly Mooney
+353 (0) 1 661 4055
Chairman's Statement
Our principal activities during this period were driving ahead Clontarf's
lithium business in South America, by participating in the evolving 2024-25
Bolivian convocatoria, and helping develop the EU's Critical Resource
Initiative, especially by perfecting extraction technologies, negotiating with
offtakers, and financing sources.
Innovating Direct Lithium & Magnesium Extraction from brines:
• Our confidence in the potential of new Direct Extraction Techniques to
transform the industry by increasing purities, minimising deleterious
elements, and boosting throughput, has been vindicated.
• Laboratory & pilot plant testing of samples provided by YLB, and
previous sampling campaigns, as well as synthetic brines, are highly
encouraging - as are more extensive brines' production runs, including those
based on observed Uyuni chemistries.
• By solving, together with our technical partners, the need to extract
100% of contained Magnesium, we have opened up potentially two independent
income streams - both Lithium and Magnesium.
• The initial pilot plant of our JV technical partner NEXT-ChemX is
progressing well at a trusted partner's industrial site in India, where
synthetic samples were processed during 2024/25. We now have the technical
and commercial confidence to build larger-scale production plants, whether in
Bolivia or elsewhere, as soon as legal and commercial requirements are
satisfied.
• The Magnesium breakthrough may enable development of salares, in
additional countries, that would not have been economic at current prices
through production of their Lithium content alone.
• Concern over security of supply of both mining and processing of
Critical Resource Minerals is now mainstream - not just in Japan and China,
but also in the USA and Europe. Off-takers are now open to financing
arrangements, while EU funding is available for infrastructural development.
• The next stage is to complete the Memorandum of Understanding with the
Bolivian State Lithium Company (YLB), and process further large brine volumes
through the pilot-plant in India.
Reinforcing legal parameters in Bolivia
There is now broad consensus within the Bolivian authorities on economic and
operating parameters. They have built on past experience, especially the
world-class gas discoveries from innovative exploration from 1995 through
2000, followed by a slump in new discoveries when companies slashed investment
due to legal uncertainty; all stakeholders are better off when reserves are
growing rather than declining. Reasonable tax rates often yield higher
returns than excessive fiscal terms that restrict economic progress. For
projects to work, they must work for all stakeholders.
But all contracts must respect the prevailing law and constitution. The
authorities have laboured to clarify and update the 2017 Lithium Law so as to
avoid future issues, and thereby facilitate EU and private sector financing.
Much progress has been made since we first explored brines, though as of May
2025, this reform has not been entirely implemented. Accordingly, the
initial contracts (both service and joint venture agreements) have not yet
been ratified. As the August 2025 elections approach, electoral dynamics
have distracted policy-makers.
Because of the high level of interest, and logistics' challenges, the
authorities adjusted dates and details for sampling, site visits, financial
criteria, and detailed negotiations. Effectively, this prioritised the
earliest convenios signed with state-backed Chinese and Russian companies from
the 2021 convocatoria. In accordance with the rules of the 2024
convocatoria, the next to be negotiated were those companies (usually backed
by larger groups) with an 'AA' credit rating. Clontarf, as an explorer, did
not meet this AA goal, but it has an off-take partner which meets this
requirement. During 2024, the authorities confirmed that the rating would
henceforth influence the timing of negotiation among companies, but that the
maturity of technology would be key. The impressive performance of our JV
technical partner's pilot-plant in recovery, cost, and quality, therefore
strengthens our relative position. But the resource is big enough for many
suppliers.
Our process does not use significant volumes of fresh water, involve high
electricity use or toxic chemicals, but there are sensitivities surrounding
some alternative technologies used by other companies. Accordingly, all
participating companies have been discreet.
Since late-2024, the authorities have focused on the maturity of the
technology offered, especially whether an operating pilot plant is already
commissioned - as well as financial criteria. This makes sense, since a
proven Direct Lithium Extraction ("DLE") technology can be funded by
offtakers, who are keen to secure supplies of battery-grade Lithium. With
proven technologies, many companies will be in a position to negotiate
development contracts.
Throughout this process, the EU Commission has shown vision and leadership in
bringing together "Team Europe", while facilitating infrastructural investment
for Bolivia to join the ranks of Lithium exporters. The EU dialogue has
helped to streamline and improve selection criteria. We are optimistic that
the EU's "Global Gateway" development initiative, perhaps treating Bolivian
Lithium as a Beta project, may de-risk qualifying projects and finance
infrastructural investment, which typically constitutes two-thirds of capex of
new projects in virgin locations.
Most shareholders are long-term, with interests aligned with the business. A
few are impatient and assume that "no news is bad news" - especially during
trade tensions when markets are volatile. But all companies depend on legal
certainty, for which they need acceptable, pro-enterprise laws. It is no
secret that lengthy negotiations have continued with Bolivian communities, as
any Google search of media coverage confirms.
Likewise there are competitive sensitivities, as the EU's 2024 Critical
Resource Minerals Initiative (in which Clontarf participates) is a response to
the USA's 2022 Inflation Reduction Act, and indeed the successful Chinese
policy to dominate global Critical Resource Minerals - sharpened by periodic
Chinese export restrictions from 2010 through 2025.
To harvest the benefits of our work to date, we must protect our technology,
and that of our technical partners, but also our close relationship with the
Bolivian authorities and the EU Commission.
Following technical breakthroughs at our pilot facilities, we have worked on
the chemical and operating engineering necessary to scale-up the process,
while maintaining high quality and competitive costs. Once the authorities
are comfortable with, and sign-off on this more detailed engineering phase, we
anticipate early despatch of large bulk samples, to be followed by site-visits
to pilot-plants, as originally planned.
Lithium, Magnesium and other Critical Resource Minerals prices have been
volatile, as new supplies struggle to meet surging demand. High Lithium
prices from 2020 - 2023 attracted incremental but low-grade Chinese Lepidolite
and marginal African supplies - which are inadequate to meet fast-growing
demand over time. Shorter-run price fluctuations are driven by temporary
factors, including inventory levels, supply chain disruptions, and fears of
tariff wars.
When a centrally-planned economy like China dominates mining and especially
processing, it can manipulate price indices as part of its Critical Resource
Minerals' strategy. But medium-term commodity prices are driven by the cash
costs of the marginal supplier. Brines' sources occupy the lower 20% of the
cost curve, but the marginal hard-rock competitors' costs are now well above
current prices. This is not sustainable, and prices will rise to economic
levels - probably when trade tensions settle.
As often with growing specialty chemicals, the pendulum will swing too far
upwards, incentivising new investment. A short-term upwards price spike may
echo the early 2020s surge, but we aim to rely on long-term contracts, rather
than spot-prices or indices that are easily manipulated. What matters for
such projects is average price realised, not peaks and troughs.
In discussions with offtakers, OEMs, private and EU financiers, all parties
assumed that clean, Green high-purity Lithium salts would command a premium in
European markets over the Chinese index, and that effectively all sales would
be on the basis of long-term contracts.
Few players worry about medium-term demand growth, which is expected to have
grown by 10 times between 2020 and 2030 to 3 million tonnes of Lithium
Carbonate equivalent ("LCE") (equal to three times the 2024 demand). The
market concern is to secure reliable long-term supplies of the quality
necessary to fuel developing technologies in mobility, grid storage, and
high-tech applications.
Funding
Clontarf has successfully accessed the financial markets when necessary.
Subject to technical verification of its exploration projects, and permitting,
Clontarf is confident of being able to source adequate funding, whether in
London or Australia, for near to medium-term ongoing activities. Our
preference, where possible, is to avoid dilution by relying on offtakers or EU
institutions for necessary infrastructural support.
David Horgan
Chairman
5 June 2025
CLONTARF ENERGY PLC
CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 DECEMBER 2024
2024 2023
£ £
Share of net profit of associates and joint ventures - -
Administrative expenses (591,823) (696,452)
Impairment of exploration and evaluation assets (173,609) (173,609)
Loss from operations (765,432) (870,061)
Loss before tax (765,432) (870,061)
Income tax - -
Total comprehensive income (765,432) (870,061)
Earnings per share attributable to the ordinary equity holders of the parent
2024 2023
Pence Pence
Loss per share - basic and diluted (0.01) (0.02)
CONSOLIDATED STATEMENT OF FINANCIAL POSITION AS AT 31 DECEMBER 2024
2024 2023
£ £
Assets
Non-current assets
Intangible assets 520,825 694,434
Investment in Joint Venture 887,655 887,655
1,408,480 1,582,089
Current assets
Other receivables 13,483 -
Cash and cash equivalents 818,212 182,516
831,695 182,516
Total assets 2,240,175 1,764,605
Liabilities
Current liabilities
Trade and other liabilities (1,410,957) (1,459,890)
Total liabilities (1,410,957) (1,459,890)
Net assets 829,218 304,715
Equity
Share capital 6,509,315 6,209,315
Share premium reserve 13,517,495 12,737,395
Share based payment reserve 825,131 615,296
Retained deficit (20,022,723) (19,257,291)
Total equity 829,218 304,715
CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 DECEMBER 2024
Share Share Share Retained Total Equity
Capital Premium Reserve Based Deficit £
£ £ Payment £
Reserve
£
At 1 January 2023 5,927,065 10,985,758 247,838 (18,387,230) (1,226,569)
Issue of share capital 282,250 1,849,000 - - 2,131,250
Share issue expenses - (97,363) - - (97,363)
Share based payment charge - - 367,458 - 367,458
Total comprehensive loss for the year - - - (870,061) (870,061)
At 31 December 2023 6,209,315 12,737,395 615,296 (19,257,291) 304,715
Issue of share capital 300,000 850,000 - - 1,150,000
Share issue expenses - (69,900) - - (69,900)
Share based payment charge - - 209,835 - 209,835
Total comprehensive loss for the year - - - (765,432) (765,432)
At 31 December 2024 6,509,315 13,517,495 825,131 (20,022,723) 829,218
CONSOLIDATED CASH FLOW STATEMENT
FOR THE YEAR ENDED 31 DECEMBER 2024
2024 2023
£ £
Cash flows from operating activities
Loss for the year (765,432) (870,061)
Adjustments for
Share based payment charge 209,835 367,458
Foreign exchange (profit)/loss 2,652 (8,081)
Impairment of exploration and evaluation assets 173,609 173,609
(379,336) (337,075)
Movements in working capital:
Increase in other receivables (13,483) -
Decrease in trade and other payables (48,933) (1,566,624)
Net cash used in operating activities (441,752) (1,903,699)
Cash flows from investing activities
Additions to investment in Joint Venture - (406,405)
Additions to exploration and evaluation assets - -
Net cash used in investing activities - (406,405)
Cash flows from financing activities
Issue of ordinary shares 1,150,000 1,650,000
Share issue expenses (69,900) (97,363)
Net cash generated from financing activities 1,080,100 1,552,637
Net cash increase/(decrease) in cash and cash equivalents 638,348 (757,467)
Cash and cash equivalents at the beginning of year 182,516 931,902
Exchange loss on cash and cash equivalents (2,652) 8,081
Cash and cash equivalents at the end of the year 818,212 182,516
Notes:
1. ACCOUNTING POLICIES
There were no changes in accounting policies from those used to prepare the
Group's Annual Report for financial year ended 31 December 2024. The financial
statements have been prepared in accordance with the Companies Act 2006.
2. LOSS PER SHARE
Basic loss per share is computed by dividing the loss after taxation for the
year attributable to ordinary shareholders by the weighted average number of
Ordinary Shares in issue and ranking for dividend during the year. Diluted
earnings per share is computed by dividing the profit or loss after taxation
for the year by the weighted average number of Ordinary Shares in issue,
adjusted for the effect of all dilutive potential Ordinary Shares that were
outstanding during the year.
2024 2023
£ £
Numerator
For basic and diluted EPS Loss after taxation (765,432) (870,061)
Denominator No. No.
For basic and diluted EPS 6,884,911,244 4,791,613,788
Basic EPS (0.01p) (0.02p)
Diluted EPS (0.01p) (0.02p)
The following potential ordinary shares are anti-dilutive and are therefore
excluded from the weighted average number of shares for the purposes of the
diluted earnings per share:
No. No.
Share options 980,500,000 500,500,000
3. GOING CONCERN
The Group incurred a loss for the year of £765,432 (2023: £870,061) and had
net current liabilities of £579,263 (2023: £1,277,374) at the balance sheet
date. These conditions, as well as those noted below, represent a material
uncertainty that may cast doubt on the Group's ability to continue as a going
concern.
Included in current liabilities is an amount of £940,750 (2023: £988,926)
owed to directors in respect of directors' remuneration due at the balance
sheet date. The Group had a cash balance of £818,212 (2023: £182,516) at the
balance sheet date. The directors have prepared cashflow projections for a
period of at least 12 months from the date of approval of the financial
statements which indicate that the group has sufficient cash to fund working
capital requirements and develop existing projects. As the Group is not
revenue or cash generating it relies on raising capital from the public
market. During the year the Company raised £1,150,000 (before expenses) via
placing of shares.
As in previous years the Directors have given careful consideration to the
appropriateness of the going concern basis in the preparation of the financial
statements and believe the going concern basis is appropriate for these
financial statements. The financial statements do not include the adjustments
that would result if the Group and Company were unable to continue as a going
concern.
4. INTANGIBLE ASSETS
Exploration and evaluation assets:
Group Group
2024 2023
£ £
Cost
At 1 January 12,735,623 12,735,623
Additions - -
At 31 December 12,735,623 12,735,623
Impairment
At 1 January 12,041,189 11,867,580
Impairment 173,609 173,609
At 31 December 12,214,798 12,041,189
Carrying Value:
At 1 January 694,434 868,043
At 31 December 520,825 694,434
Segmental analysis
Group Group
2024 2023
£ £
Bolivia - -
Ghana 520,825 694,434
520,825 694,434
Exploration and evaluation assets relate to expenditure incurred in
prospecting and exploration for lithium, oil and gas in Bolivia and Ghana. The
directors are aware that by its nature there is an inherent uncertainty in
exploration and evaluation assets and therefore inherent uncertainty in
relation to the carrying value of capitalised exploration and evaluation
assets.
During 2018 the Group resolved the outstanding issues with the Ghana
National Petroleum Company (GNPC) regarding a contract for the development of
the Tano 2A Block. The Group has signed a Petroleum Agreement in relation to
the block and this agreement awaits ratification by the Ghanian government.
As ratification has not yet been achieved in the current year the directors,
as a matter of prudence, opted to write down 20% of the carrying value of the
Tano 2A Block historic expenditure. Accordingly, an impairment charge of
£173,609 was recorded in the prior and current year.
The directors believe that there were no facts or circumstances indicating
that the carrying value of the remaining intangible assets may exceed their
recoverable amount and thus no impairment review was deemed necessary by the
directors. The realisation of these intangibles assets is dependent on the
successful discovery and development of economic deposit resources and the
ability of the Group to raise sufficient finance to develop the projects. It
is subject to a number of potential significant risks, as set out below:
· licence obligations;
· exchange rate risks;
· uncertainties over development and operational costs;
· political and legal risks, including arrangements with
governments for licences, profit sharing and taxation;
· foreign investment risks including increases in taxes,
royalties and renegotiation of contracts;
· title to assets;
· financial risk management;
· going concern; and
· ability to raise finance.
Included in the additions for the year are £Nil (2023: £Nil) of directors'
remuneration.
5. INVESTMENT IN JOINT VENTURE
Group Group
2024 2023
£ £
Cost
At 1 January 887,655 -
Additions - 887,655
At 31 December 887,655 887,655
Carrying Value:
At 1 January 887,655 -
At 31 December 887,655 887,655
On 15 February 2023 the Group announced a heads of agreement around the
potential formation of a 50:50 Joint Venture with US based, OTC Markets
traded, technology company, NEXT-ChemX Corporation ("NCX") covering testing,
marketing, and deploying of NCX's proprietary (patent pending) direct lithium
ion extraction ("DLE") technology in Bolivia. Formation of the JV was subject
to final due diligence and the parties entering into formal documentation.
The terms of the JV are:
§ A 50:50 joint venture company to be formed on completion of due diligence
covering the exclusive rights to the marketing, testing and deployment of the
NCX DLE technology in Bolivia.
§ Clontarf Energy plc to contribute $500,000 in cash towards the pilot
plant construction and testing as an exclusivity fee for the use of the NCX
technology.
§ NCX will then issue shares equal to $500,000 at its next financing
(CHMX:OTC) to Clontarf Energy plc.
§ Clontarf Energy plc will issue shares as follows to NCX:
i. 385 million new Ordinary Shares on proceeding with the Pilot
Plant;
ii. 250 million new Ordinary Shares after successful pilot processing
of Bolivian brines through the NCX pilot plant; and
iii. 250 million new Ordinary Shares after entry into a construction and
processing contract between the JV and the Bolivian authorities on processing
of Bolivian brines utilising NCX processing technology.
On 5 May 2023 the Company announced that all conditions precedent had been
satisfied with respect to the JV with NCX coming into force. In this regard,
Clontarf paid NCX US$500,000 and issued 385 million new Ordinary Shares in the
capital of Clontarf of which half will be subject to a 12-month lock in
requirement.
As at 31 December 2024 no trading activity had commenced in the JV and as such
there are no results or expenses recorded.
6. TRADE AND OTHER PAYABLES
Group Group
2024 2023
£ £
Trade payables 34,503 35,261
Other accruals 25,000 25,000
Other payables 1,351,454 1,399,629
Amounts owed to group companies - -
1,410,957 1,459,890
It is the Company's normal practice to agree terms of transactions, including
payment terms, with suppliers and provided suppliers perform in accordance
with the agreed terms, payment is made accordingly. In the absence of agreed
terms it is the Company's policy that the majority of payments are made
between 30 to 40 days. The carrying amount of trade and other payables
approximates to their fair value.
Other payables include amounts due for directors' remuneration of £940,750
(2023: £988,926) accrued but not paid at year end.
7. SHARE CAPITAL
Deferred Shares - nominal value of 0.24p
Number Share Capital Share Premium
£ £
At 1 January 2023 and 2024 2,370,826,117 5,689,982 -
- - -
At 31 December 2023 and 2024 2,370,826,117 5,689,982 -
Ordinary Shares - nominal value of 0.01p
Allotted, called-up and fully paid:
Number Share Capital Share Premium
£ £
At 1 January 2023 2,370,826,117 237,083 10,985,758
Issued during the year 2,822,500,000 282,250 1,849,000
Share issue expenses - - (97,363)
At 31 December 2023 5,193,326,117 519,333 12,737,395
Issued during the year 3,000,000,000 300,000 850,000
Share issue expenses - - (69,900)
At 31 December 2024 8,193,326,117 819,333 13,517,495
Movements in issued share capital
On 18 March 2024 the Company raised £400,000 via a placing of 1,142,857,143
ordinary shares at a price of 0.035p per share. Proceeds raised were used to
provide additional working capital and fund development costs.
On 23 May 2024 the Company raised £300,000 via a placing of 857,142,857
ordinary shares at a price of 0.035p per share. Proceeds raised were used to
provide additional working capital and fund development costs.
On 24 September 2024 the Company raised £450,000 via a placing of
1,000,000,000 ordinary shares at a price of 0.045p per share. Proceeds raised
were used to provide additional working capital and fund development costs.
Share Options
A total of 980,500,000 share options were in issue at 31 December 2024 (2023:
500,500,000). These options are exercisable, at prices ranging between 0.10p
and 0.725p, up to seven years from the date of granting of the options unless
otherwise determined by the Board. Further information relating to Share
Options is outlined in Note 8 below.
8. SHARE BASED PAYMENTS
The Group issues equity-settled share-based payments to certain directors and
individuals who have performed services for the Group. Equity-settled
share-based payments are measured at fair value at the date of grant. Shares
granted to individuals and directors will vest immediately.
Fair value is measured by the use of a Black-Scholes model.
The Group plan provides for a grant price equal to the average quoted market
price of the ordinary shares on the date of grant.
Share Options
31 December 2024 31 December 2023
Options Weighted average exercise price in pence Options Weighted average exercise price in pence
Outstanding at beginning of year 500,500,000 0.035 40,500,000 0.7
Issued 480,000,000 0.045 460,000,000 0.08
Expired - - - -
Outstanding at end of year 980,500,000 0.09 500,500,000 0.035
Exercisable at end of year 980,500,000 0.09 500,500,000 0.035
On 9 April 2024 a total of 160,000,000 options with an exercise price of
0.0365p were granted with a fair value of £56,981. On 17 June 2024 a total of
160,000,000 options with an exercise price of 0.0385p were granted with a fair
value of £59,321. On 27 September 2024 a total of 160,000,000 options with an
exercise price of 0.06p were granted with a fair value of £93,533. These fair
values were calculated using the Black-Scholes valuation model. These options
are valid for seven years and fully vested at 31 December 2024.
The inputs into the Black-Scholes valuation model were as follows:
Granted 9 April 2024
Weighted average share price at date of grant (in
pence) 0.0365p
Weighted average exercise price (in pence)
0.0365p
Expected volatility
165.90%
Expected life
7 years
Risk free rate
4.25%
Expected dividends
none
Granted 17 June 2024
Weighted average share price at date of grant (in
pence) 0.0385p
Weighted average exercise price (in pence)
0.0385p
Expected volatility
153.03%
Expected life
7 years
Risk free rate
4.25%
Expected dividends
none
Granted 27 September 2024
Weighted average share price at date of grant (in
pence) 0.06p
Weighted average exercise price (in pence)
0.06p
Expected volatility
164.74%
Expected life
7 years
Risk free rate
3.75%
Expected dividends
none
Expected volatility was determined by management based on their cumulative
experience of the movement in share prices. The terms of the options granted
do not contain any market conditions within the meaning of IFRS 2
The Group capitalised expenses of £Nil (2023: £Nil) and expensed costs of
£209,835 (2023: £367,458) relating to equity-settled share-based payment
transactions during the year.
Warrants
31 December 2024 31 December 2023
Warrants Weighted average exercise price in pence Warrants Weighted average exercise price in pence
Outstanding at beginning of year 533,183,300 0.22 435,683,300 0.25
Issued 97,500,000 0.065
Expired (97,500,000) 0.065 - -
Outstanding at end of year 435,683,300 0.25 533,183,300 0.22
In connection to the placing on 16 January 2023 the Company issued 97,500,000
warrants over 97,500,000 Ordinary Shares to the brokers involved in the
Placing. The warrants had a term of one year, and an exercise price of 0.065p.
These warrants expired in the current year.
9. OTHER RESERVES
Share Based Payment Reserve
£
Balance at 1 January 2023 247,838
Vested during the year 367,458
Balance at 31 December 2023 615,296
Issued during the year 209,835
Balance at 31 December 2024 825,131
Share Based Payment Reserve
The share based payment reserve arises on the grant of share options under the
share option plan as detailed in Note 8.
10. RETAINED DEFICIT
2024 2023
£ £
Opening Balance (19,257,291) (18,387,230)
Loss for the year (765,432) (870,061)
Closing Balance (20,022,723) (19,257,291)
Retained Deficit
Retained deficit comprises of losses incurred in the current and prior years.
11. POST BALANCE SHEET EVENTS
There were no material post balance sheet events affecting the Company or
Group
12. ANNUAL GENERAL MEETING
The Company's Annual General Meeting will be held on Monday 14 July 2025 at
12.00pm at Hilton London Paddington, 146 Praed Street, London, W2 1EE, United
Kingdom.
13. GENERAL INFORMATION
The financial information set out above does not constitute the Company's
audited financial statements for the year ended 31 December 2024 or the year
ended 31 December 2023. The financial information for 2023 is derived from the
financial statements for 2023 which have been delivered to Companies House.
The auditors had reported on the 2023 statements; their report was unqualified
and did not contain a statement under section 498(2) or 498(3) of the
Companies Act 2006. The financial statements for 2024 will be delivered to
Companies House.
A copy of the Company's Annual Report and Accounts for 2024 will be mailed
shortly only to those shareholders who have elected to receive it. Otherwise,
shareholders will be notified that the Annual Report will be available on the
website www.clontarfenergy.com (http://www.clontarfenergy.com) . Copies of
the Annual Report will also be available for collection from the Company's
registered office, Dept 4046A, 126 East Ferry Road, Canary Wharf, London, E14
9FP, United Kingdom
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END FR UPUBUQUPAPGARecent news on Clontarf Energy
See all newsREG - Clontarf Energy PLC - Holding(s) in Company
AnnouncementREG - Clontarf Energy PLC - Preliminary Results
AnnouncementREG - Clontarf Energy PLC - TR-1: Notification of major holdings
AnnouncementREG - Clontarf Energy PLC - Grant of Share Options
AnnouncementREG - Clontarf Energy PLC - Bolivia Update, Fundraising and TVR
Announcement